Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,012 total articles
AeroVironment sits at the intersection of rising Drones-as-a-Service demand, defense spending tailwinds, and advanced R&D in sensors and communications. The stock has stabilized after a sharp correction tied to a government stop-work order; fundamentals show scale, a $14.3B market cap, and meaningful cash, but earnings remain negative and free cash…
Wynn Resorts is a premium casino-resort operator with strong free cash flow, attractive EV/EBITDA relative to quality peers, and a multi-year growth runway backed by a $5.1B development in the UAE. This trade idea proposes a long position at current prices with clear entry, stop, and target levels and a time horizon aligned to key catalysts and reo…
Intuit is trading well below its 52-week highs after a software-sector swoon tied to AI fears. Fundamentals remain strong: $108B market cap, $6.4B free cash flow, 21% ROE, low leverage and a broad suite of subscription businesses (QuickBooks, TurboTax, Credit Karma). The technicals look stretched (RSI ~22) and headline risk is high, but AI integrat…
Micron is squarely in the crosshairs of the AI-driven memory shortage. Fundamentals — accelerating DRAM/HBM pricing, ROE near 20%, and improving cash generation — plus a clean balance sheet and heavy capex commitments, create a high-reward setup into 2027. This trade idea lays out an actionable long with entry, stop and target, plus the catalysts a…
Avient is morphing from a cyclical compounding business into a steadier specialty polymer supplier. Recent earnings mix improvements, consistent free cash flow of $151.1M, and a manageable balance sheet support a long trade on a near-term pullback. Technicals are hot, so patience and a defined stop are needed.
Uber trades at ~$150B market cap while showing stretched valuation vs. the recent slowdown in price momentum. Technicals are weak, short interest is stable, and expansion headlines do not justify the current multiple. This trade targets a move back toward the low-$60s over a mid-term horizon with strict risk controls.
Estée Lauder ($EL) has bounced back from last year's low and looks set to continue repairing its top-line and cash-generation profile. Market cap sits near $41.8B, free cash flow is about $1.14B, and the stock is trading well above its 50-day and 10-day SMAs. That said, recently announced tariffs (a ~$100M headwind) and stretched valuation metrics …
Coherent (COHR) is trading near $224 with a market cap around $42.5B after a string of strong data-center and networking orders. Recent beats and raised guidance underpin a patient long idea: buy a starter position on weakness, add on confirmation, and hold through a 180-trading-day cycle as AI networking and industrial laser recovery play out. Val…
Advanced Micro Devices is trading near $198 after a pullback. With a $323B market cap, robust free cash flow of roughly $6.7B and exposure to AI servers, graphics, and custom accelerators, I view the current weakness as a buying opportunity. My plan: scale in around $198.22, protect with a $170 stop, and run to $300 over the next 180 trading days i…
GEO (The GEO Group) trades near cycle lows after political noise and higher costs pushed investors out. Fundamentals and valuation point to a partial rebound; this trade targets a mid-term rally toward $18 while protecting capital with a tight stop near the 52-week low.
Alphabet's AI stack — anchored by Gemini and an expanding Google Cloud — is moving from tech promise to commercial revenue. With a $3.66T market cap, P/E near 27.6, and free cash flow of ~$73B, Alphabet offers a high-quality, liquid way to play broad AI adoption. This trade idea lays out an entry, stop, target, and horizon with catalysts and balanc…
Nvidia just extended its hyperscaler dominance: a multiyear deal with Meta to supply Blackwell/Rubin GPUs and Grace/Vera CPUs meaningfully increases revenue visibility for 2026. The trade is to buy NVDA on a confirmed breakout with a stop below recent support and a target near the 52-week high — a mid-term swing that balances momentum and valuation…
I upgraded Celestica (CLS) to a tactical long after the stock found consistent support near $286. The balance sheet, free cash flow generation and an accepted normal course issuer bid give the company optionality even if near-term customer mix is noisy. This trade idea lays out a mid-term (45 trading days) plan with entry, stop and target and the k…
BitMine Immersion Technologies is effectively an ETH treasury with a public equity wrapper. The stock is trading on depressed technicals near $20 while the company controls meaningful Ethereum reserves. This trade idea targets a mid-term re-rating as crypto sentiment stabilizes and ETH price recovers.
Itron's recent operational momentum, strategic tuck-ins (Urbint and Locusview) and exposure to a growing smart-utilities market give the stock a favorable risk/reward. Valuation metrics (P/E ~15, EV/EBITDA ~12) and robust free cash flow underpin a swing trade setup with defined entry, stop and target levels.
Tesla looks past the carnage of 2025 and is showing signs of a sustained comeback: positive free cash flow of $6.22B, a market cap near $1.56T and technical momentum combine with a large battery storage TAM to justify a tactical upgrade. This trade plan targets $480 with a $375 stop for a mid-term push tied to improving fundamentals and several nea…
Tourmaline Oil offers amplified exposure to North American natural gas demand while trading at a valuation that, in my view, understates the company’s free-cash-flow potential and capital returns optionality. With management putting their own capital to work, I’m initiating a risk-sized long with a defined stop and target over a 180 trading day hor…
Uber is no longer just a ride-hailing company. With nascent robotaxi deployments, expanded delivery markets in Europe, and ongoing AI partnerships, the company pairs a platform-level moat with profitable unit economics. At ~$72.60 today, Uber looks like a reasonable long for investors willing to hold for operational progress in autonomy and margin …
Snap reported 946 million monthly active users and beat Q4 estimates with $1.72B revenue. The shares are trading near a 52-week low while free cash flow and revenue growth provide a tangible path to multiple expansion. We lay out a long trade with entry, stop and target and the catalysts and risks that matter.
Amazon's ~20% drawdown from last year's highs has traders second-guessing exposure, but underlying valuations and early enterprise AI wins suggest AWS is set to convert accelerated AI demand into outsized cash flow. This trade idea outlines a long entry, clear stop, price target, and the drivers that could flip negative investor sentiment.
Global Payments (GPN) is trading at bargain multiples after a long correction. Management’s 2026 EPS guide and a $2.5B buyback create a path for a dramatic re-rating. This trade idea lays out an entry at current levels, a tight stop below the recent range, and an ambitious target that assumes multiple expansion as investors re-price the company tow…
Pfizer is offering a beaten-down valuation, a 6%+ yield, and improving clinical momentum. The stock looks attractive for a mid-term swing trade: entry near current levels, stop below the support band, target at a multiple re-rating if product wins and pipeline readouts continue to surprise. This is a trade, not a deep-value buy-and-hold call; risk …
Hinge Health combines fast top-line growth with improving margins and substantial free cash flow. Recent Q4 results beat expectations, and management's 2026 guide points to continued revenue growth and non-GAAP earnings expansion. The trade idea outlines a long trade with precise entry, stop and target, a rationale grounded in numbers, and a balanc…
Seaboard (SEB) combines a cash-generative pork business with a growing Marine fleet and attractive valuation. Fundamentals and recent policy tailwinds for shipping make a mid-term long trade compelling from the current ~$4,955 level. Entry at $4,955, target $5,400, stop $4,680; horizon mid term (45 trading days).
Heron Therapeutics is trading near the bottom of its recent range despite product revenue upside and board additions. Valuation is modest by biotech standards (market cap ~$232M, EV ~$315M) but cash flow is negative and shorts are crowded. This is a tactical, mid-term swing trade: enter at $1.23, stop $0.95, target $1.85 over ~45 trading days with …
